Clinical Trial Update: Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether topical sunscreen can prevent skin rash in cancer patients receiving EGFR inhibitors erlotinib or cetuximab. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Dermatologic Complications, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED